pembrolizumab
merck
['pembro', 'renal,(-adrenal)']
3 negative rcts of adjuvant immunotherapy in renal cell cancer after the positive pembro trial. how to explain? 
Personal account. Med Onc. Associate Professor @queensoncology @QueensuPHS. #cancerpolicy #globaloncology #cancergroundshot. Pubs-https://t.co/DE00s50Vpj